ClinicalTrials.gg
RecruitingNCT07422077IRESCUpdated Feb 19, 2026

Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service

An interventional study of ERCS sessions in Stress Disorders, Post-Traumatic, sponsored by Hôpital Européen Marseille. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Hôpital Européen Marseille · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 144 studies in Stress Disorders, Post-Traumatic with a site in France — 33 open to participants now, 33 under way, 3 of them phase 3. Stress Disorders, Post-Traumatic · France.

Planned enrollment
59th of 81
38 · median 92
Started
2025
with 10 others
No phase
67 of 144
18 open now
Primary completion
2027-06
later than 16 of 32 live
Registered
134th of 144
by date

Among the 144 studies in Stress Disorders, Post-Traumatic with a site in France, this one is the 59th largest by planned enrollment of the 81 interventional ones that give a count, is one of 11 that started in 2025, is one of 67 with no phase, reaches primary completion later than 16 of the 32 other live ones, and was the 134th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

33 of the 144 studies in Stress Disorders, Post-Traumatic with a site in France are open now. Recruiting first, the newest first:

27 more — sign in →

All 33 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 144 studies in Stress Disorders, Post-Traumatic with a site in France, or all of them as a file.
02

Study summary

Surviving an intensive care unit hospitalization (ICU) can be the beginning of a long rehabilitation journey, hindered by symptoms of stress, PTSD, anxiety, and depression. In order to improve the care of these patients, it's essential to explore effective non-pharmacological approaches to reduce stress. Many non-drug techniques are being developed to alleviate the physical and psychological pain of patients.

Energy Resonance by Skin Stimulation (ERCS) is a noninvasive method of soothing and supporting the patient. This technique is based on the energetic principles of traditional Chinese medicine. It relies on a "listening contact" through the stimulation of cutaneous points to create resonance and transmit vibrational and wave messages in the tissues. ERCS has various applications, whether for the management of acute or chronic pain, emotional disorders such as fear, anxiety, and depression.

Our study aims to assess the effects of ERCS on the perceived stress of patients hospitalized in the post-ICU rehabilitation service. By demonstrating its potential impact on both physical and psychological recovery, this research could support the integration of RESC into care protocols and open new perspectives for stress management in hospital settings

03

Conditions studied

  • Stress Disorders, Post-Traumatic
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged ≥ 18 years
  • Hospitalized adults in a Post-Intensive Care Rehabilitation Unit (SRPR)
  • Having given free and informed written consent

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding woman
  • Persons deprived of their liberty by a judicial or administrative decision.
  • Persons who are subject to a legal protection measure or who are unable to express their consent.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
38 participants (estimated)

Study arms

  • Other
    Patients hospitalized in the post-ICU rehabilitation service.

    Other: ERCS sessions

Interventions

  • OtherERCS sessions

    Two ERCS sessions spaced one week apart, on Day 0 and Day 7

06

What researchers measure

Primary outcomes

  1. Difference in the level of perceived stress by the patient before and immediately after the second RESC session (two sessions on day 0 and day 7), measured using a Visual Analog Scale (VAS).

    Time frame: Day 0 and day 7

Secondary outcomes

  1. Daily evolution of perceived stress (VAS) between Day 0 and Day 7

    Time frame: Day 0 and day 7

  2. Difference in pain (VAS) between, before and after each session

    Time frame: Day 0 and day 7

  3. Measurement in clinical parameters before and after each session (respiratory rate breaths per minute/bpm; heart rate beats per minute/bpm; blood pressure millimeters of mercury, mmHg; oxygen saturation percentage, %)

    Time frame: Day 0 and day 7

  4. Anxiety score (COVI scale) before and after each session

    Time frame: Day 0 and day 7

  5. Measurement of the patient's physical symptoms during the session using a binary scale for each symptom at the end of each RESC session

    Time frame: Day 0 and day 7

  6. Duration of each ERCS session

    Time frame: Day 0 and day 7

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jun 2027, 18 months after the start.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 18 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 1, 2025
First posted
Feb 19, 2026
StartActual
Dec 8, 2025
Primary completionEst.
Jun 8, 2027
CompletionEst.
Sep 8, 2027
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07422077
Lead sponsor
Hôpital Européen Marseille
Responsible party
Sponsor
First posted
Feb 19, 2026
Start date
Dec 8, 2025
Primary completion
Jun 8, 2027 (estimated)
Completion
Sep 8, 2027 (estimated)
Last update
Feb 19, 2026

Study contacts

Myriam BENNANI
Contact
m.bennani@hopital-europeen.fr
0413428351

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion